|
|
Multicenter, Phase 1B, first-in-human dose-escalation study of ADXS31-164 in patients with HER2-expressing solid tumors - SABCS 2015
Uploaded: Dec 8, 2015
Type: Pdf
|
|
|
Phase 1/2 study of ADXS31-142 and pembrolizumab in metastatic castration-resistant prostate cancer (mCRPC): The KEYNOTE-046 trial – SITC 2015
Uploaded: Nov 5, 2015
Type: Pdf
|
|
|
Phase 1/2 study of ADXS11-001 or Durvalumab in recurrent/metastatic cervical or HPV-positive head and neck cancer – SITC 2015
Uploaded: Nov 5, 2015
Type: Pdf
|
|
|
High-dose treatment with ADXS11-001 in women with cervical cancer – SITC 2015
Uploaded: Nov 5, 2015
Type: Pdf
|
|
|
Stage 1 Clinical Data from Phase 2 GOG 0265 Study in Metastatic Cervical Cancer - AGOS 2015
Uploaded: Sep 17, 2015
Type: Pdf
|
|
|
Immunotherapy of Breast Cancer - World Congress on Breast Cancer
Uploaded: Aug 4, 2015
Type: Pdf
|
|
|
Combination Lm-LLO Immunotherapy plus Radiation Delays Tumor Progression and Prolongs Survival in Osteosarcoma
Uploaded: Jun 8, 2015
Type: Pdf
|
|
|
Phase 1 study evaluating high-dose ADXS11-001 treatment in women with carcinoma of the cervix
Uploaded: Jun 1, 2015
Type: Pdf
|
|
|
Window of opportunity trial of HPV E7 antigen-expressing Listeria-based therapeutic vaccination prior to robotic surgery for HPV-positive oropharyngeal cancer
Uploaded: Jun 1, 2015
Type: Pdf
|
|
|
Phase I study evaluating high dose ADXS11-001 treatment in women with carcinoma of the cervix
Uploaded: May 26, 2015
Type: Image
|